PMV Pharmaceuticals, Inc. (PMVP)

NASDAQ: PMVP · Real-Time Price · USD

1.530

+0.030 (2.00%)

At close: Mar 5, 2026, 4:00 PM EST

1.550

+0.020 (1.31%)

After-hours: Mar 5, 2026, 7:09 PM EST

PMV Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	36.34	40.88	38.53	109.12	173.29	361.42
Short-Term Investments	92.91	128.58	165.35	132.76	124.7	-
Cash & Short-Term Investments	129.25	169.45	203.88	241.88	297.99	361.42
Cash Growth	-29.63%	-16.89%	-15.71%	-18.83%	-17.55%	256.13%
Other Current Assets	3.2	6.2	3.53	5.13	3.3	3.34
Total Current Assets	132.45	175.66	207.41	247.01	301.29	364.76
Net Property, Plant & Equipment	1.15	1.55	19.05	20.49	13.15	0.57
Long-Term Investments	-	13.84	25.51	2.5	16.91	-
Other Long-Term Assets	0.25	0.24	0.19	0.31	0.22	0.2
Total Assets	133.84	191.29	252.15	270.31	331.57	365.53
Accounts Payable	3.4	6.58	3.24	3	3.19	1.61
Accrued Expenses	8.52	7.44	9.94	7.31	8.63	4.8
Current Portion of Leases	0.39	0.35	0.85	0.53	0.4	-
Total Current Liabilities	12.3	14.37	14.03	10.83	12.22	6.41
Long-Term Leases	0.54	0.84	12.43	13.45	10.79	-
Total Long-Term Liabilities	0.54	0.84	12.43	13.45	10.79	-
Total Liabilities	12.85	15.21	26.46	24.28	23.01	6.41
Additional Paid-in Capital	549.33	544.65	535.47	487.52	476.36	469
Accumulated Other Comprehensive Income	0.09	0.14	0.22	-0.45	-0.08	-
Retained Earnings	-428.42	-368.71	-310	-241.04	-167.73	-109.88
Total Common Shareholders' Equity	121	176.08	225.69	246.03	308.56	359.12
Shareholders' Equity	121	176.08	225.69	246.03	308.56	359.12
Total Liabilities & Equity	133.84	191.29	252.15	270.31	331.57	365.53
Total Debt	0.93	1.19	13.29	13.98	11.19	0
Net Cash (Debt)	128.32	168.26	190.59	227.9	286.79	361.42
Net Cash Growth	-23.74%	-11.72%	-16.37%	-20.54%	-20.65%	256.13%
Net Cash Per Share	2.46	3.26	3.97	5.00	6.35	25.16
Book Value	121	176.08	225.69	246.03	308.56	359.12
Book Value Per Share	2.32	3.41	4.70	5.40	6.84	25.00
Tangible Book Value	121	176.08	225.69	246.03	308.56	359.12
Tangible Book Value Per Share	2.32	3.41	4.70	5.40	6.84	25.00

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q